WE BACK OUR CLAIM THAT MIKE STATHIS HOLDS THE LEADING TRACK RECORD ON THE 2008 FINANCIAL CRISIS WITH $1 MILLION. You risk $500,000 for the chance to earn $1,000,000 (we give you 2:1 odds).
ChatGPT deep analysis of Mike Stathis's investment research track record:
1) Intelligent Investor US & Emerging Markets Forecasts (2020-2024)
An overview of Mike Stathis' investment research track record: here, here, here, and here.
Stathis' 2008 Financial Crisis Track Record: [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] and [13]
Chapter 12 of Cashing in on the Real Estate Bubble (2007)
Chapter 10 of America's Financial Apocalypse (2006 original extended edition).
Chapter 16 & 17 Excerpts America's Financial Apocalypse (2006 original extended edition).
Check out our Track Record Image Library: here
ChatGPT analysis: [1] [2] [3] [4] [5] [6] and [7].
Grok-3 analysis [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] 
REQUEST FOR GROK-3: Based on the healthcare excerpts from America's Financial Apocalypse (chapter, "Prognosis Negative" and the book's investment recommendations related to healthcare, as well as ramifications of America's employer-based healthcare system during a period whereby free trade has caused millions of jobs to be sent overseas) from Mike Stathis' 2006 book America's Financial Apocalypse (not displayed due to copyright) analyze Stathis' research as an analyst given what we see today from U.S. healthcare, including recent calls by Trump to reduce drug prices, advances in healthcare IT and telemedicine, etc.
Compare his work with that of the leading healthcare analysts and experts, summarizing in a table if possible.
Key Points
Analysis of Stathis' Research
Mike Stathis' 2006 book America's Financial Apocalypse highlighted critical issues in U.S. healthcare, including the link between employment and insurance, high costs, and inefficiencies.
Given today's landscape, his predictions from twenty years ago on telemedicine and healthcare IT seem spot on, with significant growth in these areas. His concerns about drug prices align with recent efforts, like Trump's May 2025 executive order to lower prices by aligning with international rates, though outcomes are uncertain. However, his push for universal healthcare hasn't materialized, with the U.S. instead focusing on incremental reforms.
Comparison with Leading Analysts
Leading healthcare experts in 2025, like Adam J. Fein, echo Stathis' focus on technology but emphasize efficiency over systemic overhaul. They see telemedicine as transformative, driven by AI and 5G, and debate drug price controls' effectiveness, reflecting Stathis' critiques in 2006.
Survey Note: Detailed Analysis of Stathis' Research in Context of 2025 U.S. Healthcare
This survey note provides a comprehensive analysis of Mike Stathis' research from his 2006 book America's Financial Apocalypse, focusing on U.S. healthcare, and compares it with the current state in 2025, including recent developments like Trump's calls to reduce drug prices and advances in healthcare IT and telemedicine. It also contrasts his work with leading healthcare analysts and experts, ensuring a thorough examination of all relevant details.
Background on Stathis' Research
Stathis' 2006 book addressed several pressing issues in the U.S. healthcare system, as evidenced by the provided excerpts.
He emphasized the problematic link between employment and health insurance, noting that job losses due to outsourcing, particularly under free trade agreements, left millions without coverage.
He highlighted the high cost of healthcare, with the U.S. spending more per capita than any other nation yet achieving relatively low quality outcomes, ranked 17th globally among developed nations.
Stathis criticized the profiteering by HMOs, insurance companies, and pharmaceutical firms, arguing that these entities prioritized profits over patient care, contributing to inefficiencies and waste.
He advocated for a national healthcare system, pointing out that the lack of universal coverage, unlike in Europe and Asia, undermined U.S. competitiveness and economic stability.
Additionally, he discussed the inadequacies of Medicare and Medicaid, predicting financial burdens from the baby boomer generation, and foresaw growth in telemedicine and healthcare IT as cost-effective solutions.
Current U.S. Healthcare Landscape in 2025
As of May 13, 2025, several developments align with or diverge from Stathis' predictions:
Comparison with Leading Healthcare Analysts and Experts
Leading healthcare analysts and experts in 2025 provide insights that both align with and diverge from Stathis' views:
Detailed Comparison and Analysis
To organize the comparison, the following table summarizes the key aspects:
|
Aspect |
Stathis' Research (2006) |
Current Developments (2025) |
Expert Opinions (2025) |
|
Drug Prices |
High costs due to lack of price controls; advocated for controls |
Trump's executive order to align prices with other countries; Inflation Reduction Act |
Mixed views on effectiveness; concerns about implementation and industry impact |
|
Telemedicine |
Predicted growth as a cost-effective solution |
Significant market growth; integration of AI and 5G |
Seen as transformative for access and efficiency |
|
Universal Healthcare |
Advocated for a national system |
No move towards universal healthcare; focus on reforms and technology |
Emphasis on improving access through technology rather than systemic overhaul |
|
Healthcare IT |
Highlighted as key to cost reduction and efficiency |
Rapid adoption; focus on data analytics, AI, and telehealth |
Central to future healthcare delivery and cost management |
Stathis' foresight on telemedicine and healthcare IT is validated by 2025 trends, with significant market growth and technological integration. His concerns about drug prices remain relevant, with recent policies attempting to address them, though experts debate their effectiveness. However, his call for universal healthcare has not been adopted, with the U.S. focusing on technological and policy reforms instead. This reflects the complexity of healthcare policy, with industry lobbying and political resistance playing significant roles, as Stathis noted.
Conclusion
Stathis' 2006 research was prescient in predicting the growth of telemedicine and healthcare IT, which have become integral to 2025 healthcare delivery. His critique of high drug prices aligns with current efforts, though outcomes are uncertain.
While his advocacy for universal healthcare has not materialized, the U.S. has made incremental progress through reforms and technology, reflecting a nuanced approach to addressing healthcare challenges.
Leading experts echo his focus on technology but prioritize efficiency over systemic change, highlighting ongoing debates and the need for balanced solutions.
Key Citations
Restrictions Against Reproduction: No part of this publication may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, scanning, or otherwise, except as permitted under Section 107 or 108 of the 1976 United States Copyright Act, without the prior written permission of the copyright owner and the Publisher.
These articles and commentaries cannot be reposted or used in any publications for which there is any revenue generated directly or indirectly. These articles cannot be used to enhance the viewer appeal of any website, including any ad revenue on the website, other than those sites for which specific written permission has been granted. Any such violations are unlawful and violators will be prosecuted in accordance with these laws.
Article 19 of the United Nations' Universal Declaration of Human Rights: Everyone has the right to freedom of opinion and expression; this right includes freedom to hold opinions without interference and to seek, receive and impart information and ideas through any media and regardless of frontiers.
This publication (written, audio and video) represents the commentary and/or criticisms from Mike Stathis or other individuals affiliated with Mike Stathis or AVA Investment Analytics (referred to hereafter as the “author”). Therefore, the commentary and/or criticisms only serve as an opinion and therefore should not be taken to be factual representations, regardless of what might be stated in these commentaries/criticisms. There is always a possibility that the author has made one or more unintentional errors, misspoke, misinterpreted information, and/or excluded information which might have altered the commentary and/or criticisms. Hence, you are advised to conduct your own independent investigations so that you can form your own conclusions. We encourage the public to contact us if we have made any errors in statements or assumptions. We also encourage the public to contact us if we have left out relevant information which might alter our conclusions. We cannot promise a response, but we will consider all valid information.